ICU Ed and Todd-Cast

Old/New: HALT-IT and TXA in GI Bleed with cirrhosis

Apr 23, 2024
Explore the benefits of using tranexamic acid in managing upper gastrointestinal bleeding in cirrhosis patients based on the HALT-IT study findings. Delve into the use of tranexamic acid in critical care, analyzing the design, outcomes, and implications for patient groups. Discuss the enrollment triggers for drug use post-HALT-IT study and interpret relative risk increase in GI bleed with cirrhosis for accurate treatment decisions.
Ask episode
Chapters
Transcript
Episode notes
1
Intro
00:00 • 3min
2
Update on ICU admissions for variceal bleed and banter on reading habits and spelling
02:48 • 2min
3
Tranexamic Acid in Upper Gastrointestinal Bleeding with Cirrhosis
04:35 • 2min
4
Tranexamic Acid in Critical Care: HALT-IT Trial and Insights
06:53 • 12min
5
Discussion on Enrollment, Triggers for Drug Use, and Avoiding High-Risk Patients after HALT-IT Study
19:20 • 2min
6
Interpreting Relative Risk Increase and Treatment Triggers in GI Bleed with Cirrhosis
21:05 • 2min
7
Trial of Trans-examic Acid in Upper GI Bleeding with Cirrhosis
22:38 • 18min